JPRN-UMIN000016058招募中未知
Clinical trial of lumbar fusion in combination with platelet rich plasma(PRP) and allograft. - Clinical trial of lumbar fusion in combination with PRP and allograft.
Graduate school of medicine chiba univresity0 个研究点目标入组 34 人开始时间: 2014年12月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 34
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 55years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. severe systemic complication for example, heart failure,renal failure, liver failure, respiratory failure 2.anamnesis of AMI and cardiac hypofunction 3.complication of severe angina 4.severe renal function failure 5..severe lever function failure 6.respiratory functional failure 7.diabetes more than HbA1c9.0 8.psycological complication 9.pregnancy 10.hypersensitivity for thrombin 11.cardiac stimulation medication hypercalcemia 12.inadequate patients 13.disturbance of consciousness
研究者
相似试验
已完成
不适用
A randomized controlled trial of lumbar fusion in combination with platelet-rich plasma(PRP)JPRN-UMIN000011501Chiba University Hospital160
已完成
不适用
umbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group.Chronic Low Back PainMusculoskeletal - Other muscular and skeletal disordersACTRN12615000162516Sahlgrenska University Hospital294
招募中
2 期
A randomized controlled trial of the lumbar-type of HAL for the safety and efficacy in hemiplegic patients with acute strokeCerebral infarction and cerebral hemorrhage patients with hemiplegia and sit-to-stand disorderCerebral infarction, Cerebral hemorrhageJPRN-jRCTs032230039Matsumaru Yuji44
招募中
不适用
A clinical study on safety and efficacy of combined intraarterial cisplatin and 5-fluorouracil with systemic pegylated interferon alfa-2b for advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000009107Iwate Medical University60
进行中（未招募）
1 期
Clinical trial of efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis in lung transplant recipients.EUCTR2018-003300-39-ESFundación para la Investigación Biomédica de Córdoba150